Affordable Access

An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.

Authors
  • Thase, Michael E
  • Kornstein, Susan G
  • Germain, Jean-Michel
  • Jiang, Qin
  • Guico-Pabia, Christine
  • Ninan, Philip T
Type
Published Article
Journal
CNS spectrums
Publication Date
Mar 01, 2009
Volume
14
Issue
3
Pages
144–154
Identifiers
PMID: 19407711
Source
Medline
License
Unknown

Abstract

Desvenlafaxine demonstrated short-term efficacy for treating major depressive disorder across the range of doses studied. No evidence of greater efficacy was observed with doses >50 mg/day; a strong dose-response effect on tolerability was observed.

Report this publication

Statistics

Seen <100 times